Sonographic evaluation of the uterus in postmenopausal women receiving tamoxifen: characterization of mid-uterine abnormalities
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study characterized mid-uterine abnormalities detected via sonography in postmenopausal women undergoing tamoxifen therapy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BackgroundTamoxifen is known to exert agonist estrogenic effects on the uterus. Its use in postmenopausal women has also been associated with various endometrial and uterine abnormalities that can be detected by endovaginal sonography.ObjectiveTo study postmenopausal patients receiving tamoxifen who were referred for evaluation following the detection of abnormal uterine findings by endovaginal sonography.MethodsFifty-two women treated with tamoxifen for breast cancer who were found to have an abnormal uterine sonogram constituted the study population. Uterine sonograms were reviewed and clinical and sonographic data were correlated with the results of the histologic examinations.ResultsForty-five women demonstrated a thickened mid-uterine structure. Of these, in thirty-nine patients (87%) either no tissue of scant fragments of normal endometrium were obtained on curettage, and six women (13%) had endometrial hyperplasia. Seven women had fluid loculation lined by thin endometrium. Their subsequent histologic examination was normal. The sonograms of the women who demonstrated an appearance of a thickened endometrium but no neoplasia, characteristically demonstrated hyperechogenic cystic area with no midline echo.ConclusionsAmong 52 postmenopausal patients receiving tamoxifen presented with an abnormal uterine sonogram, 39 (75%) women were found to have a thick mid-uterine structure resembling a thickened endometrium without histologic evidence of neoplasia. This phenomenon can be characterized by typical sonographic features, and may be differentiated from other uterine abnormalities.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer via openalex
- Hysteroscopic follow-up during Tamoxifen treatment via openalex
- Screening transvaginal ultrasonography of postmenopausal women in a private office setting via openalex
- TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM via openalex
- Thickened endometrium in the postmenopausal woman: sonographic-pathologic correlation. via openalex
- Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen via openalex
- W6663785281 via openalex
- W6713446965 via openalex
- W6718289250 via openalex
- doi:10.1007/bf00682705 via openalex
- doi:10.1016/s0140-6736(65)92229-4 via openalex
- doi:10.7863/jum.1986.5.5.275 via openalex
- doi:10.1016/0140-6736(92)90997-h via openalex
- doi:10.1111/j.1749-6632.1986.tb16002.x via openalex
- doi:10.1046/j.1469-0705.1994.04010083.x via openalex
- doi:10.1007/978-3-642-84745-5_21 via openalex
- doi:10.1016/0140-6736(92)91521-9 via openalex
- doi:10.1016/s0140-6736(88)90765-9 via openalex
- doi:10.7863/jum.1993.12.5.275 via openalex
- doi:10.2214/ajr.160.4.8456669 via openalex
- W183420292 via openalex
- doi:10.1016/s0140-6736(88)92675-x via openalex
- doi:10.1016/s0140-6736(89)91141-0 via openalex
- doi:10.1016/0090-8258(90)90371-q via openalex
- W2405102052 via openalex
- W2438890976 via openalex
- W6607443594 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T06:21:44.532445+00:00
- unpaywall
- last seen: 2026-08-24T06:27:14.670421+00:00
License: CC0
· commercial use OK